Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Equities research analysts at Leerink Partnrs dropped their Q4 2024 earnings per share estimates for United Therapeutics in a ...

WARREN, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy ...

Travere (TVTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Health industry leaders and advocates come together for The Boston Globe's Rare Disease Summit, featuring powerful conversations with the rare disease community on Tuesday, February 25, 2025 from 10 a ...

Oncotelic Therapeutics, a leader in RNA-based therapeutics, is pleased to announce that Vuong Trieu, Ph.D., Chairman & CEO, will be delivering a featured presentation at the SWCR 2025 Conference on ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, today announced the appointment of Alan Colowick, M.D ...

The transplant, part of a three-person compassionate use study, used a pig kidney with 69 gene edits provided by U ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...